Mostrar el registro sencillo de la publicación
Mortalidad a 30 días posterior a la administración de quimioterapia sistémica en una unidad oncológica regional
| dc.contributor.author | Pulgar-Boin, Dahiana A. | |
| dc.contributor.author | Yáñez B., Nicolás | |
| dc.contributor.author | Ortega Gonzales, Francisco | |
| dc.date.accessioned | 2023-01-04T19:24:40Z | |
| dc.date.available | 2023-01-04T19:24:40Z | |
| dc.date.issued | 2019 | |
| dc.identifier.uri | http://repositorio.ucm.cl/handle/ucm/4344 | |
| dc.description.abstract | Background: The use of systemic chemotherapy has survival and palliation benefits in oncological patients. Mortality at 30 days after the administration of systemic chemotherapy is considered as a quality and safety indicator of oncological patient care. The international mortality threshold is 5%, which is the figure used to compare institutions. Aim: To assess mortality at 30 days after the administration of ambulatory systemic chemotherapy in a regional referral center in adult cancer patients. Material and Methods: Retrospective observational study of patients receiving ambulatory systemic chemotherapy in the oncology service of a regional public hospital during 2018. The 30-day mortality rate was calculated. Demographic characteristics, baseline disease and the treatment received were recorded. Results: During the study period, 690 patients received ambulatory systemic chemotherapy. Chemotherapy was palliative in 76% of patients and 53% received a first line treatment. Seventeen (2.5%) died within 30 days of treatment administration. Nine deaths (52.9%) were definitely related to treatment and sepsis was the most frequent cause. Conclusions: Our mortality rates are similar to international data. This type of audit reviews local outcomes and identifies factors contributing to mortality aiming to improve standards of care. | es_CL |
| dc.language.iso | es | es_CL |
| dc.rights | Atribución-NoComercial-SinDerivadas 3.0 Chile | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/cl/ | * |
| dc.source | Revista Médica de Chile, 147(7), 887-890 | es_CL |
| dc.subject | Antineoplastic agents | es_CL |
| dc.subject | Benchmarking | es_CL |
| dc.subject | Mortality | es_CL |
| dc.title | Mortalidad a 30 días posterior a la administración de quimioterapia sistémica en una unidad oncológica regional | es_CL |
| dc.title.alternative | Mortality within 30 days of receiving systemic chemotherapy at a regional oncology unit | es_CL |
| dc.type | Article | es_CL |
| dc.ucm.facultad | Facultad de Medicina | es_CL |
| dc.ucm.indexacion | Scopus | es_CL |
| dc.ucm.indexacion | Isi | es_CL |
| dc.ucm.indexacion | Scielo | es_CL |
| dc.ucm.uri | www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872019000700887&lng=en&nrm=iso&tlng=en | es_CL |
| dc.ucm.doi | doi.org/10.4067/S0034-98872019000700887 | es_CL |
Ficheros en la publicación
| Ficheros | Tamaño | Formato | Ver |
|---|---|---|---|
|
No hay ficheros asociados a esta publicación. |
|||
Esta publicación aparece en la(s) siguiente(s) colección(ones)
Excepto si se señala otra cosa, la licencia de la publicación se describe como Atribución-NoComercial-SinDerivadas 3.0 Chile